These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 475375)

  • 21. [Clinical experiences with human fibroblast interferon (author's transl)].
    Furue H; Komita T; Kobayashi H; Hakozaki M; Kondo S; Tajima S
    Nihon Gan Chiryo Gakkai Shi; 1981 Apr; 16(2):220-8. PubMed ID: 6168714
    [No Abstract]   [Full Text] [Related]  

  • 22. [The functioning of the interferon system with different methods and dosages of recombinant alpha 2-interferon (reaferon) administration].
    Malinovskaia VV; Murzabaeva RT; Manakhova LS; Mironova LL
    Vopr Virusol; 1989; 34(2):180-3. PubMed ID: 2474904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical application of fibroblast interferon--an overview.
    Billiau A
    Med Oncol Tumor Pharmacother; 1984; 1(2):87-96. PubMed ID: 6400034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics of human interferons].
    Furue H; Kobayashi H; Komuro T; Kako M; Mugitani H; Fuse K; Kaise R; Nagai K; Takahashi T; Hirota F
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):935-42. PubMed ID: 6721508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearance of human interferon in rabbits induced to make rabbit interferon.
    Pyhala L; Cantell K
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):394-7. PubMed ID: 4834448
    [No Abstract]   [Full Text] [Related]  

  • 26. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.
    Ponvert C; Perrin Y; Bados-Albiero A; Le Bourgeois M; Karila C; Delacourt C; Scheinmann P; De Blic J
    Pediatr Allergy Immunol; 2011 Jun; 22(4):411-8. PubMed ID: 21535179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating interferon in rabbits after administration of human interferon by different routes.
    Cantell K; Pyhälä L
    J Gen Virol; 1973 Jul; 20(1):97-104. PubMed ID: 4356685
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of human fibroblast interferon on vaccination in volunteers.
    Scott GM; Cartwright T; LeDu G; Dicker D
    J Biol Stand; 1978 Jan; 6(1):73-6. PubMed ID: 342530
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha 2 interferon in patients with malignancies.
    Shah I; Band J; Samson M; Young J; Robinson R; Bailey B; Lerner AM; Prasad AS
    Am J Hematol; 1984; 17(4):363-71. PubMed ID: 6594039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physico-chemical characteristics of interferons induced by human adenovirus in chick fibroblasts and leucocytes.
    Taródi B; Pusztai R; Berencsi K
    Acta Virol; 1975 Sep; 19(5):393-400. PubMed ID: 241243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two antigenically distinct species of human interferon.
    Havell EA; Berman B; Ogburn CA; Berg K; Paucker K; Vilcek J
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):2185-7. PubMed ID: 49055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of systemic fever reaction of the delayed type hypersensitivity. 3. Some conditions of the release of a pyrogenic substance during the cultivation of blood cells with specific antigen in vitro.
    Castrová A; Pekárek J; Johanovský J
    Int Arch Allergy Appl Immunol; 1968; 33(4):313-26. PubMed ID: 5649603
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of the translation products of human fibroblast interferon mRNA in reticulocyte lysates.
    Weissenbach J; Zeevi M; Landau T; Revel M
    Eur J Biochem; 1979 Jul; 98(1):1-8. PubMed ID: 467436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralizing antibodies against human leukocyte, lymphoblastoid and fibroblast interferons elicited by immunization with human leukocyte interferon.
    Pyhälä
    Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):291-8. PubMed ID: 726897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered pharmacologic properties of liposome-associated human interferon-alpha. II.
    Eppstein DA
    J Interferon Res; 1982; 2(1):117-25. PubMed ID: 6180100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of fever accompanying delayed hypersensitivity. The role of the sensitized lymphocyte.
    Atkins E; Feldman JD; Francis L; Hursh E
    J Exp Med; 1972 May; 135(5):1113-32. PubMed ID: 4112261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Induction of endogenous pyrogen and interferon by Newcastle disease virus in vivo].
    Shu HL; Tan TP
    Arch Gesamte Virusforsch; 1970; 29(4):287-94. PubMed ID: 5450126
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell-mediated hypersensitivity in rabbits infected with Trypanosoma brucei and Trypanosoma rhodesiense.
    Tizard IR; Soltys MA
    Infect Immun; 1971 Dec; 4(6):674-7. PubMed ID: 5154901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I pharmacotoxicology study of human fibroblast interferon in human cancers.
    McPherson TA; Tan YH
    J Natl Cancer Inst; 1980 Jul; 65(1):75-9. PubMed ID: 6156261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin.
    Schlievert PM; Bettin KM; Watson DW
    Infect Immun; 1979 Nov; 26(2):467-72. PubMed ID: 161910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.